Studies on medical Marijuana
Studies on medical Marijuana – despite the development of the field and the implementation of many studies in recent decades, the hidden is more evident in the case of Marijuana and active substances in it.
However, biological, statistical and chemical findings in the field of Marijuana have been found in the studies at an increasing rate, and the proliferation of evidence leads to changes in the medical and civil legislation.
Here is a brief overview of some of these studies:
Studies on medical Marijuana – University of Arizona: Marijuana consumption does not harm health, but smoking affects gums.
A study of a group of 1,307 New Zealanders from birth to age of age followed their smoking habits and their effect on accepted physical health measures, such as lung function, systemic infections, cholesterol levels, blood pressure, weight, blood sugar and health Teeth and mouth.
The findings are surprising: After considering factors that have a known health impact, particularly cigarette smoking and socioeconomic status, Marijuana consumption has no adverse effect on physical health, except on the gums.
Subjects who consumed more Marijuana in smoking were at risk of gum disease. In this context, it is noted that in order to avoid the damage caused by smoking, Marijuana flowers can be vaporized using designated devices.
Studies on medical Marijuana – the Netherlands: Comparing the effect of alcohol consumption on aggression, relative to the consumption of Marijuana.
Despite the familiar stereotype of the soothing effects of Marijuana on its users, it is also known that the active substance THC has possible side effects of paranoia, panic and confusion.
There have been a number of cases in which users have harmed themselves or others, and studies have even confused the effects of Marijuana on aggression among its users.
Maastricht University in the Netherlands carried out a study to confirm or refute the new claims.
Three groups were recruited: the first consisted of 20 adults drinking a few alcoholic beverages a day (3 + for men + 2 for women), 21 adults who smoked Marijuana at least three times a week, and a control group of 20 adults who did not drink or smoke Marijuana significantly.
After group 1 was allowed to drink up to the legal level as judged to be impaired, and the group was allowed to smoke 300 mg of THC per kg of body mass, both performed actions designed to increase the level of aggression, Buttons to win money against an opponent who can cheat in the game and take away some of the money they won. After the game the levels of aggression were measured objectively, meaning that the participants indicated their level of aggression. After a week the tests were performed again, this time without the influence of any materials. The results were also normal for the control group.
It was found that the alcohol consumer group was more aggressive in relation to themselves under influence, and Marijuana consumers were less aggressive under the influence, relative to themselves.
Studies on medical Marijuana – University of Colorado: The frequency of migraines decreased from 10 migraines in less than 5 month
The study was conducted on a group of 121 adults with migraines at an average frequency of 10 migraines per month, for whom a clinical Marijuana for migraines was diagnosed and prescribed by a private practice.
103 out of 121 patients reported migraine prevention, reduction of frequency, and / or cessation of migraines as they occurred.
In the group of patients who reported adverse effects, the main complaints were about feelings of sleepiness or difficulty in controlling the side effects of Marijuana consumption, particularly in relation to the size of the dose consumed and the timing of the effect, in patients who consumed only edible Marijuana products.
The Lenox-Gasteau syndrome is a difficult type of treatment for epilepsy (about 5% of the cases) that erupts in childhood, usually between the ages of two and six.
The study shows that Epidylax, based largely on CBD cannabinoids produced by Marijuana, is effective in stopping epileptic seizures in patients with Lennox Gesto syndrome, and 2016 positive results in the treatment of epileptic seizures in children with dervous syndrome, which affects children under the age of 1 and is not known for drug therapy . The company conducting the study is GW Pharma, which developed a drug for multiple sclerosis based on THC. This drug was approved in 2010 and became the first Marijuana drug in the world.